Comparison of conventional oral cyclosporine and cyclosporine microemulsion formulations in children with a liver transplant: A pharmacokinetic and clinical study

Transplantation

Volumn 62, Issue 1, 1996, Pages 66-71

  Hoppu, Kalle ^a   Jalanko, Hannu ^a   Laine, Jarmo ^a   Holmberg, Christer ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; EMULSIONS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; METABOLIC CLEARANCE RATE;

EID: 0029979904     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00014     Document Type: Article

References (13)

1. Esquivel CO, Martinez O, Krams S, et al. Liver transplantation at California Pacific Medical Center, San Francisco, California. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 163.
2. Drewe J, Meier R, Vonderscher J, et al. Enhancement of the oral absorption of cyclosporin in man. Br J Clin Pharmacol 1992; 34: 60.
3. Freeman D, Grant D, Levy G, et al. Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients. Ther Drug Monit 1995; 17: 213.
4. Mueller EA, Kovarik JM, van Bree JB, Tetzloff W, Grevel J, Kutz K. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 1994; 11: 301.
5. Kahan BD, Dunn J, Fitts C, et al. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995; 59: 505.
6. Laine J, Krogerus L, Fyhrquist F, Jalanko H, Rönnholm K, Holmberg C. Renal function and histopathology after liver transplantation in children. J Pediatr 1994; 125: 863.
7. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics, 3rd ed. Philadelphia: Lea & Febiger, 1984.
8. Atkison PR, Grant DR, Williams SE, Howard J, Wall WJ, Stiller CR. Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin A. Transplant Proc 1994; 26: 2953.
9. Superina RA, Strong DK, Acal LA, DeLuca E. Relative bioavailability of Sandimmune and Sandimmune Neoral in pediatric liver recipients. Transplant Proc 1994; 26: 2979.
10. Dunn SP, Cooney GF, Kulinsky A, et al. Absorption characteristics of a microemulsion formulation of cyclosporine in deNovo pediatric liver transplant recipients. Transplantation 1995; 60: 1438.
11. Hoppu K, Koskimies O, Holmberg C, Hirvisalo EL. Pharmacokinetically determined cyclosporine dosage in young children. Pediatr Nephrol 1991; 5: 1.
12. Ptachcinski RJ, Venkataramanan R, Rosenthal JT, et al. The effect of food on cyclosporine absorption. Transplantation 1985; 40: 174.
13. Gupta SK, Manfro RC, Tomlanovich SJ, et al. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration. J Clin Pharmacol 1990; 30: 645.